Business
Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel
The Global Cell and Gene Therapy Third-Party Logistics Market is projected to surge to US$ 20.98 billion by 2033, up from US$ 8.66 billion in 2024, growing at a CAGR of 10.33%. Key growth drivers include technological advancements in cold chain logistics, an increase in clinical studies, and the rise of personalized medicine. The expanding demand for cell and gene therapies necessitates temperature-sensitive logistics solutions. Major players like Cardinal Health and McKesson Corporation are enh
About this update from Mckesson Corporation
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The Global Cell and Gene Therapy Third-Party Logistics Market is projected to surge to US$ 20.98 billion by 2033, up from US$ 8.66 billion in 2024, growing at a CAGR of 10.33%. Key growth drivers include technological advancements in cold chain logistics, an increase in clinical studies, and the rise of personalized medicine. The expanding demand for cell and gene therapies necessitates temperature-sensitive logistics solutions. Major players like Cardinal Health and McKesson Corporation are enhancing infrastructure and creating seamless supply chains, ensuring the safe and effective transport of these critical therapies. The market is primed for robust growth, driven by innovations and strategic partnerships across global regions.","length":741,"tagName":"p"},{"type":"text","content":"Cell and Gene Therapy Third-Party Logistics Market","length":50,"tagName":"p"},{"type":"image","alt":"Cell and Gene Therapy Third-Party Logistics Market","displaySize":"","headline":null,"caption":"Cell and Gene Therapy Third-Party Logistics Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/0e16d886360cd133e42c3adf0151d742"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TJtUqRYnUcrAdcoElNRzLQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/0e16d886360cd133e42c3adf0151d742","width":600,"height":400}}},{"type":"text","content":"Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Third-Party Logistics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering.The Global Cell and Gene Therapy Third-Party Logistics Market is expected to reach US$ 20.98 billion by...